How Dabur Turned a Doctor's Bicycle Deliveries in 1884 Into the World's Largest Ayurvedic Empire Worth Rs 12,400 Crore

In the mid-1880s, in the congested bylanes of Calcutta (now Kolkata), a physician named Dr. S. K. Burman pedaled through streets on his bicycle, carrying jars of herbal medicines he had prepared at home. Cholera and malaria ravaged the city. The poor had no access to affordable healthcare. Existing treatments were expensive, often ineffective, and beyond the reach of ordinary people.

Dr. Burman—affectionately called "Daktar Burman" (daktar meaning "doctor" in Bengali)—spent his days concocting medicines with various herbs and plants based on ancient Ayurvedic formulations passed down through generations. His remedies worked. Word spread among Calcutta's underprivileged communities that Daktar Burman's medicines brought genuine relief.

But there was a problem: On his bicycle, he could reach only a handful of patients daily. Remote villages and towns had no access to his treatments. The physician who had dedicated his life to making healthcare accessible faced a distribution challenge that would define his legacy.

His solution was revolutionary for 1884: mail-order medicine delivery. This innovation, combined with his commitment to affordability and efficacy, laid the foundation for what would become Dabur—a portmanteau of "Daktar" and "Burman."

Today, 141 years later, Dabur is the world's largest Ayurvedic healthcare company with revenues exceeding Rs 12,400 crore, operating in 120+ countries through 8.5 million retail outlets, offering 250+ herbal and Ayurvedic products, and maintaining a market capitalization that makes the Burman family one of India's wealthiest dynasties.

This is the story of how one doctor's bicycle deliveries became a global Ayurvedic empire—and how four generations of the Burman family transformed a traditional medicine practice into a professionally-managed FMCG powerhouse.

1884: The Founding Mission

Dr. S. K. Burman founded Dabur in 1884 in Calcutta with a singular mission: produce and dispense Ayurvedic medicines to reach a wide mass of people who had no access to proper treatment.

His Ayurvedic formulations—rooted in ancient texts passed down through generations—targeted killer diseases ravaging colonial India: cholera, constipation, malaria, and plague. The medicines worked because Dr. Burman was a qualified physician who understood both traditional Ayurvedic wisdom and practical application.

As a qualified physician selling medicines personally on a bicycle, he built trust through direct patient relationships. His innovation—mail-order delivery—allowed him to reach patients in far-flung villages and towns, expanding his impact beyond what bicycle-based delivery could achieve.

Patients began calling him and his medicines "Dabur"—combining the first two letters of "Daktar" with the first three letters of his surname "Burman." The name stuck.

1896: The First Manufacturing Plant

By 1896, twelve years after founding, demand for Dr. Burman's remedies had grown so substantially that mail-order and small-batch production couldn't keep pace.

Dr. Burman established Dabur's first manufacturing plant for mass production of his formulations. This marked the transition from artisanal medicine-making to industrial-scale manufacturing—a critical evolution that would enable Dabur to serve millions rather than thousands.

1919: The Research Foundation

In 1919, Dr. Burman's son C.L. Burman established Dabur's first research and development unit for medicines, introducing mechanization to enhance production.

The need to develop scientific processes and quality checks for mass production of traditional Ayurvedic medicines led to the establishment of research laboratories. This fusion of ancient Ayurvedic knowledge with modern scientific validation became Dabur's competitive advantage—differentiating it from both traditional practitioners (who lacked scale) and pharmaceutical companies (who lacked Ayurvedic expertise).

1936: Formal Incorporation

In 1936, the business officially became Dabur India (Dr. S. K. Burman) Pvt. Ltd.—formalizing the corporate structure and solidifying family control.

New manufacturing units were established in Narendrapur and Daburgram. Distribution networks expanded to Bihar and Northeast India. The company was systematically building the infrastructure necessary for national scale.

1940s: The Amla Hair Oil Innovation

In the 1940s, Dabur started producing hair oil with amla (Indian gooseberry)—one of the first such products in the country. This marked Dabur's expansion beyond medicines into personal care, a diversification that would eventually transform the company's business model.

Dabur Amla Hair Oil would become one of India's most iconic brands, nourishing generations and establishing Dabur in the consumer goods space beyond just pharmaceuticals.

1960s: Moving Beyond Calcutta

By the 1960s, three generations of the Burman family lived together in one house—seven families totaling dozens of family members under the same roof. Although families had different living spaces, they ate meals together every day, discussing ways to improve the business.

Every elder groomed younger ones to run the business. This intergenerational knowledge transfer ensured continuity while maintaining quality standards and business philosophy.

However, the late 1960s and throughout the 1970s brought crisis. Calcutta became a hotbed of political and social turmoil. The Naxalite movement gathered steam in West Bengal. Trade unions became assertive and sometimes aggressive. Workers began seeing businessmen as class enemies. Industries closed down.

Many companies—including the Birla Group and State Bank of India—moved headquarters out of Calcutta.

Dabur made the same difficult decision: relocate to Delhi.

1972: The Delhi Move

Dabur's operations shifted to Delhi. A new manufacturing plant was set up in temporary premises in Faridabad on the outskirts of Delhi—a massive undertaking that required relocating manufacturing, employees, and operations to an entirely different region.

1973-1975: The Sahibabad Plant

In 1973, commercial production started in the new Sahibabad factory—one of the largest and best-equipped production facilities for Ayurvedic medicines at the time.

In 1975, full-fledged research operations were launched in pioneering areas of healthcare with the establishment of the Dabur Research & Development Centre (DRDC).

1986: Going Public

In 1986, Dabur became a Public Limited Company, transitioning from private family holding to publicly traded entity with thousands of shareholders and regulatory oversight.

1991: Reverse Merger

In 1991, Dabur India Ltd. came into being after reverse merger with Vidogum Limited—a corporate restructuring that simplified the organizational structure.

1993: The Public Issue

In 1993, Dabur India Ltd. raised its first public issue. Due to market confidence, shares issued at a high premium were oversubscribed 21 times—extraordinary validation of Dabur's brand strength and growth potential.

1997-1998: The Professionalization

By 1998, Dabur was managed by the fourth and fifth generations of the Burman family. The business had expanded from medicines to hair oils, chyawanprash, toothpaste, and more. But growth wasn't accelerating as the family desired.

They consulted McKinsey & Company, who made an unusual suggestion: The Burmans would have to give up day-to-day control. They would need to hire professional CEOs, CFOs, and other executives from outside the family.

This was revolutionary for an Indian family business in 1998. For the first time in Dabur's 114-year history, a non-family professional CEO sat at the helm.

The Burman family formulated a Family Council that acts as an interface between the family, the board, and management. Four family members—Amit, Mohit, Aditya, and Saket—represent the family on the board of directors.

2000: International Manufacturing

In 2000, Dabur opened its first overseas plant in Dubai to serve the Middle East & North Africa markets—marking the beginning of serious international expansion.

2005: Strategic Acquisitions

In 2005, Dabur acquired brands like Babool, Promise, and Odomos—significantly expanding presence in oral and personal care categories.

2011-2012: The Billion-Dollar Milestone

During the 2011-12 fiscal, Dabur India Ltd. surpassed the billion-dollar turnover mark, ending the year with net sales of Rs 5,283.17 crore.

Dabur Red Paste entered the 'Billion Rupee Brand' club—joining an elite group of Indian consumer products achieving that scale.

2013-2024: Continued Expansion

In 2013, Dabur acquired 51% of Badshah Masala Pvt Ltd, entering the food & beverages category through spices.

In October 2024, Dabur acquired 51% stake in Sesa Care Private Limited, an Ayurvedic hair care brand, further strengthening its personal care portfolio.

In 2025, Dabur UK Trading Limited was incorporated by Dabur International FZE, extending international distribution and trade capabilities.

The Current Empire

As of 2025, Dabur operates:

• Revenue: Rs 12,400+ crore

• Countries: 120+

• Retail Outlets: 8.5 million

• Products: 250+ herbal and Ayurvedic products

• Manufacturing: 12 locations in India, 8 overseas

• Ownership: Burman family holds 66.22% as promoter group (June 2025)

• Chairman: Mohit Burman

• Heritage: 141 years (founded 1884)

The Product Portfolio

Dabur's five flagship brands:

• Dabur: Master brand for natural healthcare

• Vatika: Premium personal care

• Hajmola: Digestive tablets (launched 1950s)

• Real: Juices and beverages

• Fem: Personal care

Iconic products include:

• Dabur Chyawanprash

• Dabur Amla Hair Oil

• Dabur Red Paste

• Dabur Honey

• Dabur Honitus (cough syrup)

• Dabur Ashokarishta (women's health tonic)

• Meswak toothpaste

The Legacy

From Dr. S. K. Burman pedaling through Calcutta streets in 1884 to Rs 12,400 crore revenue in 2025—from bicycle deliveries to 8.5 million retail outlets—Dabur's 141-year journey proves timeless truths.

First, purpose-driven missions compound. Dr. Burman didn't create medicines for profit—he wanted to make healthcare accessible to the poor. That authentic mission embedded in Dabur's DNA persists 141 years later.

Second, innovation solves distribution challenges. Mail-order delivery in 1884 was as revolutionary as e-commerce in the 1990s. Dr. Burman recognized that product quality meant nothing if patients couldn't access it.

Third, professionalization doesn't destroy family legacies—it protects them. The Burman family's 1998 decision to hire professional management was radical but preserved Dabur for future generations.

Fourth, heritage becomes competitive advantage when modernized. Dabur didn't abandon Ayurveda—it validated it with modern science, making ancient wisdom credible to contemporary consumers.

Finally, each generation must adapt while honoring founders. From bicycle deliveries to mail-order to mass manufacturing to FMCG diversification to professional management—each generation evolved the business model while maintaining Dr. Burman's core mission.

When families across India reach for Dabur Chyawanprash, Dabur Amla Hair Oil, or Dabur Honey today, they're accessing remedies rooted in 141-year-old Ayurvedic formulations that a Calcutta physician once delivered by bicycle to patients who couldn't afford expensive treatments.

That physician died knowing he had helped thousands. He couldn't have imagined his bicycle deliveries would become the world's largest Ayurvedic empire serving 120+ countries through 8.5 million retail outlets.

That's not just building a medicine business. That's proving that authentic purpose, continuous innovation, and multi-generational adaptation can transform one doctor's bicycle into a Rs 12,400 crore legacy—one mail-order delivery, one manufacturing plant, one professional CEO at a time.